K. Moore

Immunologic Impact and Clinical Outcomes After Surgical Exposure to Bovine Thrombin

T. Ortel, J. Lawson, E. Thames, 2001, Annals of surgery.

Antibodies to topical bovine thrombin correlate with access thrombosis.

T. Ortel, J. Sands, S. A. Nudo, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations.

T. Ortel, M. Quinn-Allen, W. Kane, 1998, Blood.

Antibodies to Prothrombin, Factor V, and &bgr;2-Glycoprotein I and Vascular Access Thrombosis

T. Ortel, J. Sands, S. A. Nudo, 2001, ASAIO journal.

Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa.

T. Ortel, N. Allen, K. D. Moore, 1999, Arthritis and rheumatism.

Structure of the gene for human coagulation factor V.

L. Cripe, W. Kane, W. H. Kane, 1992, Biochemistry.

Assessment of Primary Hemostasis by PFA-100® Analysis in a Tertiary Care Center

T. Ortel, A. James, C. Greenberg, 2000, Thrombosis and Haemostasis.

Risk factors associated with thrombosis in patients with antiphospholipid antibodies.

T. Ortel, D. Kong, K. D. Moore, 2001, The Journal of rheumatology.

Binding of factor VIII inhibitors to discrete regions of the factor VIII C2 domain disrupt phospholipid binding

T. Ortel, K. Moore, D. Lewis, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Factor VIII Arg2304 → His Binds to Phosphatidylserine and Is a Functional Cofactor in the Factor X-ase Complex

T. Ortel, K. Moore, D. Lewis, 2001, Thrombosis and Haemostasis.

Effect of Heterologous Factor V Heavy Chain Sequences on the Secretion of Recombinant Human Factor VIII

W. Kane, M. Ezban, T. Ortel, 1996, Thrombosis and Haemostasis.